EGFR/HER2/CDK9-IN-2
EGFR/HER2/CDK9-IN-2 is a potent triple inhibitor targeting EGFR, HER2, and CDK9 with respective IC50 values of 145.35, 129.07, and 117.13 nM. It demonstrates significant antitumor activity in biochemical and cellular assays, supporting its use as a research tool in oncology for studying kinase-driven cancer pathways.
Product Specifications
CAS Number
1180924-34-8
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin; Cell Biology, Signal Transduction
Smiles
C (CC1=CC=C (S (N) (=O) =O) C=C1) N2C (SCC3=CC=C (N (=O) =O) C=C3) =NC=4C (C2=O) =CC=CC4
Molecular Formula
C23H20N4O5S2
Molecular Weight
496.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![CHO Monoclonal IL-6R alpha Antibody (vobarilizumab) [Allophycocyanin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-28014APC 0.1 mL
CHO Monoclonal IL-6R alpha Antibody (vobarilizumab) [Allophycocyanin]
Sign In for Pricing
View Details 